Latest Updates
-
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet -
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens -
The Sunscreen Confusion: Expert Explains How to Choose What Actually Works in Indian Weather -
On Goa Liberation Day 2025, A Look At How Freedom Shaped Goa Into A Celebrity-Favourite Retreat -
Daily Horoscope, Dec 19, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs
Cancer-Inhibiting Compound Found Under The Sea

University of Florida College of Pharmacy researchers claim to have found a marine compound that can halt cancer progression.
The researchers say that the compound found off the cost of Key Largo has been found to inhibit cancer cell growth in laboratory tests, giving hope that new drugs to better battle the disease may soon be available.
A presentation on the efficacy of the UF-patented compound largazole, derived from cyanobacteria that grow on coral reefs, was made at an international natural products scientific meeting in Athens, Greece.
Experts attending the meeting described largazole as one of the most promising they had found since the college's marine natural products laboratory was established three years ago.
"It's
exciting
because
we've
found
a
compound
in
nature
that
may
one
day
surpass
a
currently
marketed
drug
or
could
become
the
structural
template
for
rationally
designed
drugs
with
improved
selectivity," said
Dr.
Hendrik
Luesch,
an
assistant
professor
in
UF's
department
of
medicinal
chemistry,
and
the
principal
investigator
on
the
study.
A research article in the Journal of the American Chemical Society reveals that largazole, discovered and named by Luesch for its Florida location and structural features, seeks out a family of enzymes called histone deacetylase (HDAC).
Background information in the article suggests that over-activity of certain HDACs is associated with several cancers like prostate and colon tumours, and inhibiting them can activate tumour-suppressor genes that have been silenced in these cancers.
Luesch says that a largazole-based drug might result in improved therapies and fewer side effects, given that this compound does not inhibit all HDACs equally.
His team has now joined forces with Jiyong Hong, an assistant professor in the department of chemistry at Duke University, to conduct further biological testing on the compound.
Luesch has revealed that, within the next few months, he plans to study whether largazole reduces or prevents tumour growth in mice.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











